ArticleBiomolecules2019
Physicochemical Characterization and Antioxidant Activity Evaluation of Idebenone/Hydroxypropyl-
Open access · goldAbstract read
In one paragraph
Article in Biomolecules, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.
0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
3.6field-weighted citation impact, top 6% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
34 citing papers in PubMed, 72 citations in OpenAlex.
- Advantages of the Combined Use of Cyclodextrins and Chitosan in Drug Delivery: A Review.Pharmaceutics · 2026Review
- Cyclodextrin-Based Formulations as a Promising Strategy to Overcome the Blood-Brain Barrier: Historical Overview and Prospects in Glioblastoma Treatment.Pharmaceuticals (Basel, Switzerland) · 2025Review
- Polymer-free β-cyclodextrins and mefenamic acid inclusion complex nanofibers for enhanced drug solubility and biomedical applications.Scientific reports · 2025Article
- Options for Topical Treatment of Oxidative Eye Diseases with a Special Focus on Retinopathies.Medicina (Kaunas, Lithuania) · 2024Review
- Article
- Advantages of Induced Circular Dichroism Spectroscopy for Qualitative and Quantitative Analysis of Solution-Phase Cyclodextrin Host-Guest Complexes.International journal of molecular sciences · 2023Article
- Cyclodextrin Inclusion Complexes for Improved Drug Bioavailability and Activity: Synthetic and Analytical Aspects.Pharmaceutics · 2023Review
- Characterization and In Vivo Antiangiogenic Activity Evaluation of Morin-Based Cyclodextrin Inclusion Complexes.Pharmaceutics · 2023Article
- Central and Peripheral Fatigue Evaluation during Physical Exercise in Athletic Horses by Means of Raman Spectroscopy.Animals : an open access journal from MDPI · 2023Article
- Synthesis and Characterization of PCL-Idebenone Nanoparticles for Potential Nose-to-Brain Delivery.Biomedicines · 2023Article
- Amphiphilic Cyclodextrin Nanoparticles as Delivery System for Idebenone: A Preformulation Study.Molecules (Basel, Switzerland) · 2023Article
- Article
- Ιnclusion Complexes of Magnesium Phthalocyanine with Cyclodextrins as Potential Photosensitizing Agents.Bioengineering (Basel, Switzerland) · 2023Article
- Formulation of Multicomponent Chrysin-Hydroxy Propyl β Cyclodextrin-Poloxamer Inclusion Complex Using Spray Dry Method: Physicochemical Characterization to Cell Viability Assessment.Pharmaceuticals (Basel, Switzerland) · 2022Article
- Bicalutamide Anticancer Activity Enhancement by Formulation of Soluble Inclusion Complexes with Cyclodextrins.Biomolecules · 2022Article
- Chitosan/Cyclodextrin Nanospheres for Potential Nose-to-Brain Targeting of Idebenone.Pharmaceuticals (Basel, Switzerland) · 2022Article
- Molecular Fingerprinting of the Omicron Variant Genome of SARS-CoV-2 by SERS Spectroscopy.Nanomaterials (Basel, Switzerland) · 2022Article
- Article
- Preliminary study for the application of Raman spectroscopy for the identification of Leishmania infected dogs.Scientific reports · 2022Article
- Raman Spectroscopic Study of Amyloid Deposits in Gelatinous Drop-like Corneal Dystrophy.Journal of clinical medicine · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors at 4 institutions in 1 country.
Valentina VenutiDipartimento di Scienze Matematiche e Informatiche, Scienze Fisiche e Scienze della Terra, Università degli Studi di Messina, V.le F. Stagno D'Alcontres, 31-98166 Messina, Italy. vvenuti@unime.it.ORCID 0000-0003-2907-9165
Vincenza CrupiDipartimento di Scienze Chimiche, Biologiche, Farmaceutiche e Ambientali, Università degli Studi di Messina, V.le F. Stagno D'Alcontrés, 31-98166 Messina, Italy. vcrupi@unime.it.
Barbara FazioCNR-IPCF Istituto per i Processi Chimico Fisici, V.le F. Stagno d'Alcontres, 37-98158 Faro Superiore, Messina, Italy. fazio@me.cnr.it.
Domenico MajolinoDipartimento di Scienze Matematiche e Informatiche, Scienze Fisiche e Scienze della Terra, Università degli Studi di Messina, V.le F. Stagno D'Alcontres, 31-98166 Messina, Italy. dmajolino@unime.it.ORCID 0000-0002-2934-2587
Giuseppe AcriDipartimento di Scienze Biomediche, Odontoiatriche, e delle Immagini Morfologiche e Funzionali, Università degli Studi di Messina, c/o A.O.U. Policlinico "G. Martino" Via Consolare Valeria, 1-98125 Messina, Italy. gacri@unime.it.ORCID 0000-0002-8897-2853
Barbara TestagrossaDipartimento di Scienze Biomediche, Odontoiatriche, e delle Immagini Morfologiche e Funzionali, Università degli Studi di Messina, c/o A.O.U. Policlinico "G. Martino" Via Consolare Valeria, 1-98125 Messina, Italy. btestagrossa@unime.it.
Rosanna StancanelliDipartimento di Scienze Chimiche, Biologiche, Farmaceutiche e Ambientali, Università degli Studi di Messina, V.le F. Stagno D'Alcontrés, 31-98166 Messina, Italy. rstancanelli@unime.it.
Federica De GaetanoDipartimento di Scienze Chimiche, Biologiche, Farmaceutiche e Ambientali, Università degli Studi di Messina, V.le F. Stagno D'Alcontrés, 31-98166 Messina, Italy. fedegaetano@unime.it.
Agnese GagliardiDipartimento di Medicina Clinica e Sperimentale, Università degli Studi di Catanzaro "Magna Græcia", Campus Universitario "S. Venuta", Viale S. Venuta-88100 Germaneto, Catanzaro, Italy. gagliardi@unicz.it.
Donatella PaolinoDipartimento di Medicina Clinica e Sperimentale, Università degli Studi di Catanzaro "Magna Græcia", Campus Universitario "S. Venuta", Viale S. Venuta-88100 Germaneto, Catanzaro, Italy. paolino@unicz.it.ORCID 0000-0002-5223-9879
Giuseppe FlorestaDipartimento di Scienze del Farmaco, Università degli Studi di Catania, V.le A. Doria, 6-95125 Catania, Italy. giuseppe.floresta@unict.it.ORCID 0000-0002-0668-1260
Venerando PistaràDipartimento di Scienze del Farmaco, Università degli Studi di Catania, V.le A. Doria, 6-95125 Catania, Italy. vpistara@unict.it.
Antonio RescifinaDipartimento di Scienze del Farmaco, Università degli Studi di Catania, V.le A. Doria, 6-95125 Catania, Italy. arescifina@unict.it.ORCID 0000-0001-5039-2151
Cinzia A VenturaDipartimento di Scienze Chimiche, Biologiche, Farmaceutiche e Ambientali, Università degli Studi di Messina, V.le F. Stagno D'Alcontrés, 31-98166 Messina, Italy. caventura@unime.it.ORCID 0000-0002-8743-2046
University of Messina · ITUniversity of Catania · ITMagna Graecia University · ITInstitute for Chemical and Physical Processes · IT
Funding
No grant is acknowledged in the PubMed record.
Abstract
Idebenone (IDE) is an antioxidant drug active at the level of the central nervous system (CNS), whose poor water solubility limits its clinical application. An IDE/2-hydroxypropyl-
Indexed as
2-Hydroxypropyl-beta-cyclodextrinAnimalsAntioxidantsCattleCells, CulturedCell SurvivalDose-Response Relationship, DrugHumansL-Lactate DehydrogenaseModels, MolecularStructure-Activity RelationshipUbiquinone2-Hydroxypropyl-beta-cyclodextrinAntioxidantsidebenoneL-Lactate DehydrogenaseUbiquinone(2-hydroxypropyl)-β-cyclodextrinantioxidant activityexcised bovine nasal mucosaidebenoneinclusion complexphysicochemical characterizationU373 cells
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.